|
BRAND NAME |
GENERIC NAME |
CONDITION |
DOSAGE FORM |
ANTICIPATED LAUNCH |
|
Rayos (1, 2, 5 mg) ® |
Prednisone |
Treats inflammation of the skin, joints, lungs, and other organs |
Tablets |
2024 |
|
Myrbetriq® |
Mirabegron |
Used to treat overactive bladder |
Tablets |
2024 |
|
Ibrance® |
Palbociclib |
Used to treat breast cancer |
Cap |
2024 |
|
Teflaro® |
Ceftaroline |
Used to treat bacterial infections |
Injection |
2024 |
|
Corlanor ® |
Ivabradine |
Used to treat heart failure |
Tab & Solution |
2024 |
|
Edurant® |
Rilpivirine |
Used to treat HIV |
Tab |
2024 |
|
Qtern ® |
Dapagliflozin/Saxagliptin |
Used to lower blood sugar in patients with high blood sugar |
Tablet |
2024 |
|
Victoza® |
Liraglutide |
Used to lower blood sugar in patients with high blood sugar |
Injection |
2024 |
|
Complera® |
Emtricitabine, Rilpivirine, Tenofovir |
Used to treat HIV |
Tablets |
2024 |
|
Omidria® |
Ketorolac 0.3%/Phenylephrine 1% |
Used during eye surgery & to lower eye pain after eye surgery |
Injection |
2024 |
|
Ofev® |
Nintedanib |
Used to treat idiopathic pulmonary fibrosis or certain other lung problems |
Capsule |
February 2024 |
|
Estrogel® |
Estradiol |
Used to treat signs of menopause |
Gel |
February 2024 |
|
Isentress ® |
Raltegravir Potassium |
Used to treat HIV |
Tablets |
April 4, 2024 |
|
Atorvaliq® Suspension |
Atorvastatin Suspension |
Used to lower bad cholesterol and triglycerides, and raise good cholesterol (HDL) |
Suspension |
May 2024 |
|
Duavee® |
Bazedoxifene Acetate; Estrogens, Conjugated |
Used to treat low estrogen levels and soft, brittle bones after menopause |
Tablets |
May 2024 |
|
Jesduvroq® |
Daprodustat |
Used to treat anemia |
Tablets |
May 2024 |
|
Motpoly XR® |
Lacosamide |
Used to treat seizures |
Capsules |
May 2024 |
|
Zirgan® |
Ganciclovir |
Used to treat a viral infection of the eyes |
Ophthalmic Gel |
May 2024 |
|
Inbrija® |
Levodopa |
Used to treat off episodes in people with Parkinsons disease |
Oral Inhalation |
May 2024 |
|
Xdemvy® |
Lotilaner |
Used to treat a certain eyelid disease caused by mites |
Solution/Drops |
May 2024 |
|
Opvee® |
Nalmefene |
Used to treat some overdoses |
Nasal Spray |
May 2024 |
|
Rezzayo® |
Rezafungin |
Used to treat fungal infections |
Powder |
May 2024 |
|
Filspari® |
Sparsentan |
Used to lower protein in the urine in patients who have kidney disease |
Tablet |
May 2024 |
|
Hetlioz® |
Tasimelteon |
Used to treat sleep problems |
Oral Suspension |
May 2024 |
|
Tobi Podhaler® |
Tobramycin |
Used to in people with cystic fibrosis to treat a certain type of bacterial infection |
Inhalation Powder |
May 2024 |
|
Zavzpret® |
Zavegepant |
Used to treat migraine headaches |
Spray |
May 2024 |
|
Byetta® |
Exenatide Synthetic |
Used to lower blood sugar |
Injection |
July 2024 |
|
Paxlovid® |
Nirmatrelvir and Ritonavir |
Used in certain people to treat COVID-19 |
Tablet |
August 2024 |
|
Inpefa® |
Sotagliflozin |
Used to lower the risk of hospital stays and death because of heart failure |
Tablet |
August 2024 |
|
Sprycel (20, 50, 70, 80, 100, & 140mg) ® |
Dasatinib |
Used to treat a type of leukemia |
Tablets |
September 01, 2024 |
|
Stendra ® |
Avanafil |
Used to treat erectile dysfunction |
Tablets |
October 29, 2024 |
|
Brilinta (60 mg) ® |
Ticagrelor |
Used to lower the chance of heart attack, stroke or death |
Tablets |
October 30, 2024 |
|
Nucynta® |
Tapentadol |
Used to ease pain |
Tablets |
October 2024 |
|
Nucynta ER® |
Tapentadol Extended-Release |
Used to ease pain |
Tablets |
October 2024 |
|
Litfulo® |
Ritlecitinib |
Used to treat a type of hair loss called alopecia areata |
Capsules |
November 2024 |
|
Tyvaso DPI® |
Treprostinil |
Used to treat high blood pressure in the lungs |
Inhalation Powder |
November 2024 |
|
Qsymia® |
Phentermine/Topiramate extended-release |
Used to help with weight loss in certain people |
Capsule |
December 2024 |
|
Neupro® |
Rotigotine |
Used to treat Parkinsons disease and restless leg syndrome |
Transdermal patch |
2024 |
|
Zoryve® |
Roflumilast |
Used to treat plaque psoriasis |
Cream |
2024 |
|
Miebo® |
Perfluorohexyloctane |
Used to treat dry eyes |
Solution/Drops |
2024 |
|
Namzaric® |
Donepezil/Memantine |
Used to treat dementia |
Capsule |
January 2025 |
|
Veltassa® |
Patiromer |
Used to treat high potassium levels |
Powder/Drops |
2025 |
|
Upneeq® |
Oxymetazoline |
Used to treat a drooping eyelid |
Ophthalmic Solution/Drops |
2025 |
|
Sancuso® |
Granisetron |
Used to treat upset stomach and throwing up |
Transdermal Patch |
January 22, 2025 |
|
Auryxia® |
Ferric Citrate |
Used to lower high phosphate levels and to treat anemia |
Tablet |
March 20, 2025 |
|
Jentadueto® |
Linagliptin; Metformin Hydrochloride |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Jentadueto XR® |
Linagliptin; Metformin Hydrochloride |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Tradjenta® |
Linagliptin |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Ravicti ® |
Glycerol Phenylbutyrate |
Used to treat urea cycle problems |
Oral Liquid |
July 1, 2025 |
|
Opsumit ® |
Macitentan |
Treats high blood pressure in the lungs |
Tablets |
December 5, 2025 |
|
Xeljanz ® |
Tofacitinib |
Treats some types of arthritis, ulcerative colitis and ankylosing spondylitis |
Tablets |
December 2025 |
|
Xeljanz XR® |
Tofacitinib |
Treats some types of arthritis, ulcerative colitis and ankylosing spondylitis |
Tablets |
December 2025 |
|
Bridion® |
Sugammadex |
Used to reverse the effects of some drugs |
Solution |
January 2026 |
|
Briviact ® |
Brivaracetam |
Used to treat seizures |
Tablets |
February 2026 |
|
*Actual launch dates depend on FDA approvals and may change at any time |
